Ureaplasma urealyticumModulates Endotoxin-Induced Cytokine Release by Human Monocytes Derived from Preterm and Term Newborns and Adults
Open Access
- 1 June 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (6) , 3906-3915
- https://doi.org/10.1128/iai.69.6.3906-3915.2001
Abstract
We previously observed thatUreaplasma urealyticumrespiratory tract colonization in infants with a birth weight of ≤1,250 g was associated with increases in the tracheal aspirate proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin-8 (IL-8) relative to the counterregulatory cytokine IL-6 during the first week of life (A. M. Patterson, V. Taciak, J. Lovchik, R. E. Fox, A. B. Campbell, and R. M. Viscardi, Pediatr. Infect. Dis. J. 17:321–328, 1998). We hypothesized thatU. urealyticumalters the host immune response in the presence of a coinflammatory stimulus (e.g., bacterial infection or hyperoxia) by shifting the balance of cytokine expression towards the proinflammatory cytokines. To test this hypothesis, we compared the release of TNF-α, IL-8, IL-6, and IL-10 in vitro by unstimulated andU. urealyticum(with or without lipopolysaccharide [LPS])-stimulated human monocytes from adult peripheral blood and from term and preterm cord blood.U. urealyticumalone and in combination with LPS induced concentration- and development-dependent changes in cytokine release. In vitro inoculation with low-inoculumU. urealyticum(103color-changing units [CCU]) (i) partially blocked the LPS-stimulated IL-6 release by all cells and reduced LPS-stimulated IL-10 release by preterm cells, (ii) stimulated TNF-α and IL-8 release by preterm cells, and (iii) augmented LPS-stimulated TNF-α release in all cells. In preterm cells, high-inoculumU. urealyticum(106CCU) (i) stimulated TNF-α and IL-8, but not IL-6 or IL-10, release and (ii) augmented LPS-stimulated TNF-α and IL-8 release. High-inoculumU. urealyticum(i) stimulated release of all four cytokines in term cells and IL-8 release in adult cells and (ii) augmented LPS-induced TNF-α, IL-10, and IL-8 release in term cells but did not significantly affect LPS-induced cytokine release in adult cells. We speculate thatU. urealyticumenhances the proinflammatory response to a second infection by blocking expression of counterregulatory cytokines (IL-6 and IL-10), predisposing the preterm infant to prolonged and dysregulated inflammation, lung injury, and impaired clearance of secondary infections.Keywords
This publication has 72 references indexed in Scilit:
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- The Role of Ureaplasma urealytkum in Adverse Pregnancy OutcomeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1997
- Cytokines in chronic lung disease of prematurityEuropean Journal of Pediatrics, 1996
- Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or lessThe Journal of Pediatrics, 1996
- Viral IL-10 gene therapy inhibits TNF-α and IL-1β, not IL-6, in the newborn endotoxemic mouseJournal of Pediatric Surgery, 1996
- Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: Results of a metaanalysisThe Journal of Pediatrics, 1995
- Ureaplasma urealyticum as a cause of pneumonia in preterm infants: analysis of the white cell response.Archives of Disease in Childhood: Fetal & Neonatal, 1995
- Induction of Human Neonatal Pulmonary Fibroblast Cytokines by Hyperoxia and Ureaplasma urealyticumClinical Infectious Diseases, 1993
- Ureaplasma urealyticum infection associated with acute respiratory insufficiency and death in premature infantsThe Journal of Pediatrics, 1993
- Interleukin-6 and its relation to inflammation and diseaseClinical Immunology and Immunopathology, 1992